Hypercoagulation syndrome at liver cirrhosis
The aim of review. To present modern data on hypercoagulation syndrome at liver cirrhosis.Key points. Changes in hemostasis system at liver cirrhosis have complex and ambiguous character. The total effect of all changes is frequently balanced, and the hemostatic system remains functional. However he...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2014-12-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860068117905408 |
|---|---|
| author | I. A. Kurkina M. V. Mayevskaya B. V. Silayev V. T. Ivashkin |
| author_facet | I. A. Kurkina M. V. Mayevskaya B. V. Silayev V. T. Ivashkin |
| author_sort | I. A. Kurkina |
| collection | DOAJ |
| description | The aim of review. To present modern data on hypercoagulation syndrome at liver cirrhosis.Key points. Changes in hemostasis system at liver cirrhosis have complex and ambiguous character. The total effect of all changes is frequently balanced, and the hemostatic system remains functional. However hemostasis equilibrium at liver cirrhosis is unstable. There is always potential risk of both hemorrhage and thromboses. As the possible reasons causing clotting, decrease of plasma anticoagulants level, elevation of von Willebrand factor level, decrease of ADAMTS13 protease level, changes of vascular wall and decrease of profibrinolytic factors level are taken into account. Application of anticoagulants for liver cirrhosis patients becomes an actual issue nowadays.Conclusion. Patients with liver cirrhosis are distinguished by high risk of both hemorrhagic, and thrombotic complications, that requires profound investigation of hemostasis system. Prescription of anticoagulant therapy to such patients should be based on verified thrombosis, absence of direct contra-indications, considering risk of anticoagulant therapy complications. |
| format | Article |
| id | doaj-art-a8b0d9219ac74f6e88bd10a3b8796f57 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2014-12-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-a8b0d9219ac74f6e88bd10a3b8796f572025-02-10T16:14:39ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732014-12-012463644749Hypercoagulation syndrome at liver cirrhosisI. A. Kurkina0M. V. Mayevskaya1B. V. Silayev2V. T. Ivashkin3State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationThe aim of review. To present modern data on hypercoagulation syndrome at liver cirrhosis.Key points. Changes in hemostasis system at liver cirrhosis have complex and ambiguous character. The total effect of all changes is frequently balanced, and the hemostatic system remains functional. However hemostasis equilibrium at liver cirrhosis is unstable. There is always potential risk of both hemorrhage and thromboses. As the possible reasons causing clotting, decrease of plasma anticoagulants level, elevation of von Willebrand factor level, decrease of ADAMTS13 protease level, changes of vascular wall and decrease of profibrinolytic factors level are taken into account. Application of anticoagulants for liver cirrhosis patients becomes an actual issue nowadays.Conclusion. Patients with liver cirrhosis are distinguished by high risk of both hemorrhagic, and thrombotic complications, that requires profound investigation of hemostasis system. Prescription of anticoagulant therapy to such patients should be based on verified thrombosis, absence of direct contra-indications, considering risk of anticoagulant therapy complications.https://www.gastro-j.ru/jour/article/view/1154liver cirrhosishypercoagulationhemostasisanticoagulantsthrombosis |
| spellingShingle | I. A. Kurkina M. V. Mayevskaya B. V. Silayev V. T. Ivashkin Hypercoagulation syndrome at liver cirrhosis Российский журнал гастроэнтерологии, гепатологии, колопроктологии liver cirrhosis hypercoagulation hemostasis anticoagulants thrombosis |
| title | Hypercoagulation syndrome at liver cirrhosis |
| title_full | Hypercoagulation syndrome at liver cirrhosis |
| title_fullStr | Hypercoagulation syndrome at liver cirrhosis |
| title_full_unstemmed | Hypercoagulation syndrome at liver cirrhosis |
| title_short | Hypercoagulation syndrome at liver cirrhosis |
| title_sort | hypercoagulation syndrome at liver cirrhosis |
| topic | liver cirrhosis hypercoagulation hemostasis anticoagulants thrombosis |
| url | https://www.gastro-j.ru/jour/article/view/1154 |
| work_keys_str_mv | AT iakurkina hypercoagulationsyndromeatlivercirrhosis AT mvmayevskaya hypercoagulationsyndromeatlivercirrhosis AT bvsilayev hypercoagulationsyndromeatlivercirrhosis AT vtivashkin hypercoagulationsyndromeatlivercirrhosis |